EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations

Caroline Ledertoug Kahn iD, Maria Wissing Rasmussen iD, Jakob Kleif iD, Inge Søkilde Pedersen, Christina Therkildsen

International Journal of Cancer · 15.08.2026 · 159 (4) · 1028-1041

DOI: 10.1002/ijc.70498 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Cancer, online erschienen am 27.04.2026. Verfasst von Caroline Ledertoug Kahn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastro Unit, Hvidovre Hospital, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Circulating Tumor DNA, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Harboefonden, AHHs Forskningspulje, Tømrermester Jørgen Holm og Hustru Elisa f. Hansens Mindelegat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of colorectal cancer (CRC) via population‐based screening programs can reduce incidence and mortality. Current screening approaches are limited by cost, accessibility, compliance, and colonoscopy capacity. Blood‐based screening of circulating tumor (ct) DNA may resolve some of these limitations. This systematic review evaluated the screening potential of blood‐based ctDNA assays in asymptomatic screening populations. We systematically searched the PubMed database (final search June 20th, 2025) for studies detecting advanced adenomas (AAs) or CRC in asymptomatic cohorts, where a blood‐based ctDNA assay had been evaluated with data on specificity, sensitivity, and/or AUC at early stages of disease. Newcastle‐Ottowa scale was used for quality assessment. Only 20 studies of 454 unique hits met our inclusion criteria. Of these, 12 studies used assays targeting specific DNA alterations, while the remaining 8 studies used complex assays. Generally, comprehensive assays such as Shield, ColonSecure, and FMBT‐CRC had the best performance for early‐stage CRC detection with sensitivities of 71%–85% and specificities of 88%–90%. Despite being tested in a small cohort, the Coloscape assay was the only assay to reach sufficient AA detection with 59% sensitivity and 92% specificity. None of the reviewed ctDNA assays demonstrated sufficient sensitivities for both AA and early‐stage CRC detection to be considered future screening tools. Screening tools based on ctDNA assays have not proved superior to fecal‐based immunochemical test (FIT) yet. Future studies need to test ctDNA screening tools in large, prospective, asymptomatic cohorts emphasizing AA, and early‐stage CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCirculating Tumor DNAEarly Detection of CancerBiomarkers, TumorHumansSensitivity and SpecificityMass ScreeningAdenoma

Stichwörter der Autor:innen

advanced adenomascell‐free DNAearly diagnosisliquid biopsypopulation‐based screening

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Gastro Unit, Hvidovre Hospital, Hvidovre, Denmark.
  • Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Surgery, Nordsjællands Hospital, Hillerød, Denmark.
  • Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Caroline Ledertoug Kahn, Maria Wissing Rasmussen, Jakob Kleif

Förderung

  • Harboefonden
  • AHHs Forskningspulje
  • Tømrermester Jørgen Holm og Hustru Elisa f. Hansens Mindelegat
  • Kræftens Bekæmpelse

Zitieren

APA

Kahn, C. L., Rasmussen, M. W., Kleif, J., Pedersen, I. S., & Therkildsen, C. (2026). Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations. International Journal of Cancer, 159(4), 1028-1041. https://doi.org/10.1002/ijc.70498

Vancouver

Kahn CL, Rasmussen MW, Kleif J, Pedersen IS, Therkildsen C. Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations. International Journal of Cancer. 2026;159(4):1028-1041. doi:10.1002/ijc.70498

BibTeX
@article{Kahn2026,
  author = {Kahn, Caroline Ledertoug and Rasmussen, Maria Wissing and Kleif, Jakob and Pedersen, Inge Søkilde and Therkildsen, Christina},
  title = {Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {4},
  pages = {1028--1041},
  doi = {10.1002/ijc.70498}
}
Kostenlos starten →